Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Results Of Vivifrail Exercise In Older Type 2 Diabetic Patients With Fraity Syndrome [NA]
Completed results from a Vivifrail exercise trial in older adults with Type 2 diabetes mellitus and frailty syndrome.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients [NA]
A completed clinical trial evaluating how starch digestibility affects cardio-metabolic and inflammatory parameters in individuals with type…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors
A Geneva-based clinical trial is evaluating gastric emptying by ultrasonography in adults with type 2 diabetes treated with GLP-1 receptor t…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Gastric Emptying - Implications for the Pathogenesis of Type 2 Diabetes
A clinical trial update discussing the role of gastric emptying in the pathogenesis of Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight [Phase 1]
Phase 1 study of NNC0519-0130 in male Chinese participants living with excess body weight has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
An observational real-world study update for FINEROD evaluating finerenone’s safety and effectiveness in chronic kidney disease with type 2 …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
NIDDK-sponsored trial update reporting on the completed study of a short-term beta-cell rest intervention in adolescents and young adults wi…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy [NA]
The AT GOAL trial (Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy) conducted by the University of Wisconsin–Madison…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes
An update on a randomized trial comparing medical therapy against metabolic surgery for type 2 diabetes mellitus and obesity, with the study…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Effects of Antipsychotics on Brain Insulin Action in Females [NA]
Clinical trial evaluating the effects of antipsychotics on brain insulin action in females; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes [NA]
This clinical trial update describes an evaluation of the Omnipod M System for adults with Type 2 Diabetes, and the study is currently activ…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial of TG103 Injection as monotherapy for Type 2 Diabetes Mellitus has completed. The study was sponsored by CSPC Baike (Shandong)…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 Diabetes [Phase 3]
This Phase 3 trial evaluates whether tributyrin supplementation improves glycemic control, inflammation, and cardiovascular risk in adults w…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: The Bennett Kids PowerUP Project [NA]
The Bennett Kids PowerUP Project trial, sponsored by Wake Forest University Health Sciences, has completed its study investigating obesity i…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Non-invasive Tests for Non-alcoholic Steato-hepatitis [NA]
This document reports an update on a clinical trial evaluating non-invasive tests for non-alcoholic steatohepatitis (NASH) with fibrosis, in…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: The Effect of Exercise on the Brain in Type 2 Diabetes [NA]
This clinical trial update notes an ongoing study sponsored by Hasselt University examining how exercise affects brain outcomes in people wi…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes [Phase 3]
A Phase 3 trial in Japanese adults with Type 2 diabetes is evaluating whether two formulations of oral semaglutide are equally safe and effe…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly
A completed clinical trial exploring gut-brain axis targets to improve cognition in elderly individuals with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and Identification of Its Associated Factors. [NA]
This clinical trial registry entry describes a study at Centre Hospitalier Universitaire de Nice assessing how common diabetes-related distr…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: TCM Syndrome Differentiation of T2DM & MetS
This clinical trial update reports the completion of a study evaluating traditional Chinese medicine syndrome differentiation in people with…
-
EMA approval · 2026-03-30EMA Authorised: Glyxambi (empagliflozin;linagliptin) — Boehringer Ingelheim International GmbH
The EMA authorised Glyxambi, a fixed-dose combination of empagliflozin and linagliptin, for the treatment of Type 2 diabetes mellitus.
-
FDA approval · 2026-03-30FDA Approved: GLIPIZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for glipizide by Actavis Pharma, Inc. under the ANDA pathway, enabling an additional or updated appr…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: CGM and DFU Healing Post-discharge [NA]
Clinical trial update noting completion of a study evaluating continuous glucose monitoring (CGM) and healing of diabetic foot ulcers after …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Power-Up: An Effectiveness Trial of the Diabetes Prevention Program [NA]
This is a completed effectiveness trial evaluating the Diabetes Prevention Program for preventing type 2 diabetes in people with prediabetes…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes [NA]
A clinical trial update describing a study that uses dynamic in vivo PET imaging and ex vivo biopsies of skeletal muscle and adipose tissue …